NCT05959447View on ClinicalTrials.gov

Evaluation of the Potential Drug-drug Interactions Between Gemfibrozil or Dabigatran Etexilate and Camlipixant

PHASE1CompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

July 26, 2023

Primary Completion Date

October 13, 2023

Study Completion Date

October 13, 2023

Conditions
CoughHealthy
Interventions
DRUG

Camlipixant

Camlipixant will be administered

DRUG

Dabigatran etexilate

Dabigatran etexilate will be administered

DRUG

Gemfibrozil

Gemfibrozil will be administered.

Trial Locations (1)

G1P 0A2

GSK Investigational Site, Québec

All Listed Sponsors
lead

Bellus Health Inc. - a GSK company

INDUSTRY